| 1 |
mitogen-activated protein kinase 1 |
MAPK1 |
20 |
22 |
prostaglandin-endoperoxide synthase 1 |
PTGS1 |
3 |
| 2 |
tumor protein P53 |
TP53 |
18 |
23 |
superoxide dismutase 1 |
SOD1 |
3 |
| 3 |
caspase 3 |
CASP3 |
16 |
24 |
topoisomerase I |
TOP1 |
3 |
| 4 |
interleukin-6 |
IL6 |
16 |
25 |
arachidonate-5-lipoxygenase |
ALOX5 |
2 |
| 5 |
Jun proto-oncogene |
JUN |
15 |
26 |
apolipoprotein B |
APOB |
2 |
| 6 |
tumor necrosis factor |
TNF |
14 |
27 |
nicotinamide phosphoribosyltransferase |
NAMPT |
2 |
| 7 |
prostaglandin-endoperoxide synthase 2 |
PTGS2 |
12 |
28 |
protein tyrosine phosphatase nonreceptor type 1 |
PTPN1 |
2 |
| 8 |
myelocytomatosis oncogene |
MYC |
11 |
29 |
protein tyrosine phosphatase
receptor type F |
PTPRF |
2 |
| 9 |
nitric oxide synthase 3 |
NOS3 |
11 |
30 |
retinoic acid receptor alpha |
RARA |
2 |
| 10 |
interleukin
1 beta |
IL1B |
10 |
31 |
retinoic acid receptor beta |
RARB |
2 |
| 11 |
peroxisome proliferator-activated
receptor gamma |
PPARG |
10 |
32 |
G protein-coupled bile acid receptor 1 |
GPBAR1 |
1 |
| 12 |
catalase |
CAT |
9 |
33 |
3-hydroxy-3-methylglutaryl-CoA reductase |
HMGCR |
1 |
| 13 |
estrogen receptor 1 |
ESR1 |
9 |
34 |
hydroxysteroid
11-beta dehydrogenase 1 |
HSD11B1 |
1 |
| 14 |
|
BCL2 |
8 |
35 |
prostaglandin I2 receptor |
PTGIR |
1 |
| 15 |
caspase 8 |
CASP8 |
8 |
36 |
RAR-related orphan receptor C |
RORC |
1 |
| 16 |
cytochrome C, somatic |
CYCS |
8 |
37 |
nuclear receptor
subfamily 1 group H member 2 |
NR1H2 |
0 |
| 17 |
mechanistic target of rapamycin kinase |
MTOR |
7 |
38 |
DNA polymerase
beta |
POLB |
0 |
| 18 |
nuclear factor (erythroid-derived 2)-like 2 |
NFE2L2 |
7 |
39 |
phosphodiesterase 4D |
PDE4D |
0 |
| 19 |
fatty acid synthetase |
FAS |
4 |
40 |
protein tyrosine phosphatase
nonreceptor type 2 |
PTPN2 |
0 |
| 20 |
peroxisome proliferator-activated receptor
alpha |
PPARA |
4 |
41 |
acid phosphatase 1 |
ACP1 |
0 |
| 21 |
NADPH
quinone acceptor oxidoreductase 1 |
NQO1 |
3 |
42 |
CD81 antigen
(target of antiproliferative antibody 1) |
CD81 |
0 |
